SwitzerReport

Independent. Trusted. Proven.

Investing

Investment analysis, share recommendations, and market insights.

“HOT” stock: Clarity Pharmaceuticals (CU6) — Investing
Premium

“HOT” stock: Clarity Pharmaceuticals (CU6)

In our “HOT” stock column, Michael Gable, Managing Director of Fairmont Equities, explains why he expect Clarity Pharmaceuticals (CU6) to continue trending higher from here and current levels are a buying opportunity.

Maureen Jordan · October 31, 2024
Our big LICs are super cheap — Investing
Premium

Our big LICs are super cheap

The big broad-based listed investment companies are currently super cheap, trading at material discounts to their NTA (net tangible asset value). Why is this so? What’s the play here? What’s my view on which “big” LIC to invest in?

Paul Rickard · October 28, 2024
Three bargain stocks! — Investing
Premium

Three bargain stocks!

In my experience over years of writing in this area, every investor is looking for cheap stocks. Today I’ve come up with three that I think fit that description.

James Dunn · October 28, 2024
Has BOQ turned the corner? — Investing, Property
Premium

Has BOQ turned the corner?

Last week, Bank of Queensland hit a 52-week share price high of $7. Let’s take a closer look at the result and what the major brokers have to say. What would it take for me to invest in BOQ?

Paul Rickard · October 21, 2024

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.